MENU
ACRV
Stock ticker:
PRICE
CHANGE
CAPITALIZATION
Acrivon Therapeutics (ACRV) Ownership - Who owns Acrivon Therapeutics?
Profile
Industry
N/A
Address
480 Arsenal Way
Phone
+1 617 207-8979
Employees
61
Web
https://www.acrivon.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
216.19M
P/E Ratio
N/A
Total Cash
180.54M
Projected Growth
N/A
Total Debt
4.22M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
5.83
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ACRV
Capitalization
216M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
181M
Total Cash/Share
5.83
Total Debt
4.22M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
216M
P/B Ratio
1.00
Cash Flow
N/A
Earnings
-2.72
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
31K
Current Ratio
16.16
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-75.56M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-35.33
Shares Held By Institutions
139M
Shares Outstanding - Current
31M
Total Liabilities
14.5M
Total Volume MTD
N/A
Value
1
Gain YTD
57.520
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
480 Arsenal Way
Phone
+1 617 207-8979
Employees
61
Web
https://www.acrivon.com